2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Conditions
Multiple Myeloma
14
Recurrence
3
Lymphoma, Non-Hodgkin
1
Leukemia, Plasma Cell
1
Leukemia, B-Cell
1
Infections
1
Immunoglobulin Light-chain Amyloidosis
1
Hematologic Diseases
1
Interventions
Trimethoprim, Sulfamethoxazole Drug Combination
9
Ciprofloxacin
8
Voriconazole
5
Vancomycin
4
Caspofungin
4
Amoxicillin-Potassium Clavulanate Combination
4
gamma-Globulins
3
Fluconazole
3
Filgrastim
3
Daptomycin
3
Antibiotic Prophylaxis
3
plerixafor
2
liposomal amphotericin B
2
Whole-Body Irradiation
2
Trimethoprim
2
Therapeutics
2
Sulfamethoxazole
2
Saline Solution
2
Ribavirin
2
Polymerase Chain Reaction
2
Piperacillin, Tazobactam Drug Combination
2
Peripheral Blood Stem Cell Transplantation
2
Pentetic Acid
2
Moxifloxacin
2
Melphalan
2
Levofloxacin
2
Lenalidomide
2
Itraconazole
2
Immunoglobulins, Intravenous
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Infections
×
idecabtagene vicleucel
×
Clear all
NCT06855121
2025-03-03
NIMMS
St. Olavs Hospital
Recruiting
400 enrolled